New paradigms in purinergic receptor ligand discovery-Reference-Cited by-同舟云学术

New paradigms in purinergic receptor ligand discovery

Published:2023-06 Issue: Volume:230 Page:109503
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Jacobson Kenneth A.^ORCID,Pradhan Balaram,Wen Zhiwei,Pramanik Asmita

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference159 articles.

1. Purinoceptors: are there families of P2X and P2Y purinoceptors?;Abbracchio;Pharmacol. Therapeut.,1994

2. Selectivity is species-dependent: characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors;Alnouri;Purinergic Signal.,2015

3. Crystal structure and subsequent ligand design of a nonriboside partial agonist bound to the adenosine A2A receptor;Amelia;J. Med. Chem.,2021

4. Stimulation of platelet P2Y1 receptors by different endogenous nucleotides leads to functional selectivity via biased signalling;Arkless;Br. J. Pharmacol.,2023

5. Pyrazin-2(1H)-ones as a novel class of selective A3 adenosine receptor antagonists;Azuaje;Future Med. Chem.,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of the role of purinergic signaling and insights into its role in cancer therapy;Pharmacology & Therapeutics;2024-10

2. Adenosine A2A signaling in mood disorders: how far have we come?;IBRO Neuroscience Reports;2024-09

3. Current treatment of Psoriasis triggered by Cytokine Storm and future immunomodulation strategies;Journal of Molecular Medicine;2024-08-30

4. Is there a biochemical basis for purinergic P2X3 and P2X4 receptor antagonists to be considered as anti-seizure medications?;Biochemical Pharmacology;2024-04

5. Editorial - Purinergic signalling: 50 years;Neuropharmacology;2024-03